Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-11

Clinical Trial Update: Steroid Eye Drops in Chronic Central Serous Chorioretinopathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating steroid eye drops for chronic central serous chorioretinopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • steroid eye drops

Snippet

Sponsor: Radboud University Medical Center | Conditions: Chronic Central Serous Chorioretinopathy | Phase 3 | Status: RECRUITING